The Permanent Secretary for Health glanced at his national health dashboard as he walked into an African Union meeting. Real-time diagnostic indicators—updated just hours earlier—summarised cancer detection rates, referral flows, and cross-border medical travel. I need to revisit these figures before today’s negotiations, he thought. Medical tourism between our countries is rising, and diagnostics sit at the centre of it.

Real-time national diagnostic intelligence in an African country: science fiction or science fact?
In 2026, this is no longer speculative. It is an available option for any country willing to adopt it.

The silent epidemic beneath healthcare progress

Since independence, the healthcare agenda in many African nations has understandably focused on physical capacity: building hospitals, installing medical equipment, and training a sovereign workforce. More recently, donor-funded, vertically integrated programmes have strengthened responses to specific diseases such as HIV, malaria, and tuberculosis. These investments were essential for nation-building and have contributed meaningfully to improved health outcomes.

Yet they left unresolved a deeper systemic weakness—one that has persisted and compounded over decades. The US National Academies of Sciences, Engineering, and Medicine have described this weakness as a “silent epidemic”: diagnostic error.

Applying the National Academies’ definition—the failure to establish or effectively communicate an accurate and timely explanation of a patient’s health problem—it is clear to anyone familiar with African healthcare systems that diagnostic error is widespread across the continent. This reflects not only persistent shortages in diagnostic capacity, but also the inefficient coordination and suboptimal use of the resources that do exist.

Diagnostic errors affect individuals and societies alike. In the United States, it is estimated that most people will experience a diagnostic error at least once in their lifetime. In many African settings, the likelihood is considerably higher. Diagnostic errors are also more dangerous than treatment errors: they are more likely to lead to preventable deaths and are often harder to detect or correct.

Healthcare delivery can be understood as four interconnected stages: community-level prevention and care-seeking; diagnosis; treatment; and follow-up. Among these, diagnosis is the most fragile and system-critical. It depends on tightly coordinated interactions between clinicians, laboratories, logistics providers, and information systems. When diagnosis fails, the consequences propagate downstream—undermining treatment decisions, confusing follow-up care, and distorting national health data.

Why diagnostics break down

Laboratory testing sits at the core of modern diagnosis. It is estimated that clinicians order a laboratory test in up to 70% of hospital encounters where such services are available. Patients are often unaware of how dependent clinical decisions are on laboratory and pathology information—from the choice of medication to the decision to refer a patient to a higher-level facility.

Decades of under-investment in laboratory systems across sub-Saharan Africa have created a significant diagnostic gap. Samples, information, and decisions frequently move slowly—or fail to move at all—through fragmented pathways between patients, laboratories, and clinicians. A biopsy may travel hundreds of kilometres to a national referral facility, only for the request form to be misplaced or the final report to never reach the treating clinician. In such cases, diagnostic knowledge exists, but it never benefits the patient.

These failures reflect breakdowns in logistics, communication, and coordination rather than a lack of clinical expertise. Even the wealthy are not immune. They too rely on local clinicians and the limited number of reference laboratories and pathologists available on the continent to make initial diagnoses, often before seeking treatment abroad.

An African solution to an African diagnostic problem

The good news is that diagnostic systems can be fixed. Coordination can be structured. Communication can be standardised. These are system failures—and systems can be redesigned.

For more than seven years, a group of African pathologists working through The Pathology Network (TPN) have been addressing this challenge in Kenya, and more recently in the United Kingdom. Together with software engineers and finance professionals, they stepped back to examine the diagnostic process end-to-end, dismantling it and rebuilding it in a form aligned with the realities of African healthcare delivery.

Drawing on decades of first-hand experience across African health systems, this group designed a diagnostic operating system intended to remain stable under the operational constraints common across the continent. Analogous to an operating system in computing, this platform provides a foundational layer that renders previously opaque diagnostic processes visible, enables precise system-level control, and allows higher-order clinical and public-health programmes to be built on top of it.

This system is known as Spes360.

What Spes360 does differently

Spes360 was created to address the practical failures that disrupt diagnostic care in African health systems. It combines software with embedded quality-management tools to improve:

• Access to laboratory testing in both rural and urban settings
• Predictable turnaround times for routine and specialised tests
• Sample referral, chain-of-custody tracking, and archiving
• Standardised laboratory quality across test types
• Consistent and reliable communication of results

At its core, Spes360 is a clinician-validated, algorithmic coordination system. It links clinics, laboratories, and specialists that may be geographically distant but are working on the care of the same patient—a common scenario across Africa. Rather than replacing clinical judgement or referral pathways, it strengthens them by ensuring that information, samples, and results move reliably between institutions.

The platform supports clinicians in selecting appropriate tests, coordinates sample transport to laboratories with the required capabilities, and facilitates assignment to pathologists when specialist interpretation is needed. It also provides structured digital workspaces for laboratories and pathologists, using internationally recognised reporting standards to improve clarity and consistency.

Crucially, Spes360 is not theoretical. It has been deployed in routine clinical practice in Kenya, where it is used by several hundred clinicians, pathologists, and laboratory professionals. To date, it has supported more than 40,000 diagnostic reports—many involving tissue pathology with accompanying digital slides. In histopathology, average turnaround times of around seven days contrast sharply with the weeks or months reported in comparable settings.

Spreading success: a licensing model for scale

Having demonstrated Spes360’s value within Kenya, TPN is now exploring its adoption as national diagnostic coordination infrastructure in other African countries through a licensing model.

Each country has its own regulatory environment, professional norms, pricing structures, healthcare organisation, and networks of trust. For this reason, Spes360 is not designed to be centrally imposed. Instead, TPN proposes partnering with trusted local public or private operators who understand their diagnostic landscape and can adapt the system accordingly.

Under this model, countries license the clinically validated Spes360 platform while retaining control over local data, test pricing, regulatory compliance, business logic, and clinical relationships. The local operator is responsible for implementation and scale-up, supported by access to Spes360’s standard operating procedures and, where required, training programmes to build local capacity.

This approach reduces implementation risk and capital costs by allowing countries to adopt a proven system rather than design one from scratch.

One of the largest barriers to scaling healthcare infrastructure is the administrative burden of creating compliant diagnostic workflows from first principles. The Spes360 licensing model addresses this by providing a complete operational blueprint, including standard operating procedures for sample procurement, biosafety, logistics tracking, reporting, and financial settlement. These workflows have been refined through sustained clinical use and aligned with ISO 15189 standards. In effect, adopting institutions license institutional memory—bypassing prolonged cycles of trial and error while maintaining quality and compliance.

Pricing is designed to reflect Spes360’s mission: expanding access to high-quality diagnostics across Africa. Country-level licensing fees are calibrated to the scale of diagnostic coordination required—across hundreds of facilities and potentially millions of patients—while allowing local operators to invest in teams and networks appropriate to their context. In doing so, the model blends local ownership with internationally benchmarked practice.

The proven path: digital infrastructure as public capacity

The idea of licensing digital infrastructure to solve national-scale problems is not new in Africa. Platforms such as eCitizen in Kenya and Irembo in Rwanda have demonstrated how shared digital systems can transform public services—reducing delays, improving transparency, and strengthening state capacity. In these cases, governments did not simply buy software; they adopted digital operating systems that reshaped how services were coordinated and monitored.

Spes360 applies this same infrastructure-first logic to diagnostics. Rather than digitising hospitals or laboratories in isolation, it provides a shared coordination layer connecting institutions involved in the care of the same patient. In ambition and structure, it seeks to play a similar role for diagnostics as eCitizen has played for public services.

A digital diagnostic grid

Spes360 emerged from day-to-day medical practice in African health systems, shaped by recurring failures that cut across borders and income levels. It was envisioned by pathologists with global training and local experience—perhaps because pathologists occupy a unique vantage point within healthcare. Working across all medical specialties, they sit at the intersection of clinical decision-making, laboratory processes, and reporting, and can see how small failures in one part of the system quietly undermine outcomes elsewhere.

Spes360 functions as a unified digital diagnostic grid linking clinicians, laboratories, specialists, and patients. Rather than a collection of disconnected applications, it operates as a single diagnostic “nervous system,” ensuring that interactions between stakeholders reinforce—rather than negate—each other. The platform is designed to integrate with artificial intelligence tools that further enhance system performance by building on structured workflows and reliable data.

AI as a consequence of structure

Artificial intelligence is often presented as an add-on to healthcare. In practice, it depends on disciplined workflows and high-quality data.

By governing the diagnostic process end-to-end—from test order to final report—Spes360 creates the conditions under which AI can be safely and usefully applied, whether to predict logistical delays, support specialist interpretation, or simplify reports for patients. Without such structure, AI in healthcare remains blind.

Peer Review and Governance

Spes360 is supported by the TPN Medical Governance Council (TMGC), a semi-autonomous body of experienced pathologists drawn from Kenya and, over time, across the African continent. The TMGC provides independent oversight of diagnostic quality and professional standards on the Spes360 platform, operating separately from commercial and operational workflows. By setting shared pathology standards and reviewing practice across participating institutions, the Council addresses a central challenge in distributed, data-driven healthcare systems: who checks the checkers? In doing so, it ensures that Spes360 functions not merely as a conduit for diagnostic data, but as a guardian of medical quality and clinical integrity.

Conclusion: diagnostics as national infrastructure

Healthcare systems are often judged by their visible assets—buildings, equipment, and workforce numbers. Yet their effectiveness depends just as much on less visible foundations: standards, coordination, workflows, and information flows.

Spes360 represents an attempt to formalise these invisible elements into licensable national infrastructure—designed by African clinicians, validated through routine clinical use, and scaled through a UK-anchored licensing model. By treating diagnostics as a coordinated system rather than a collection of isolated services, this approach offers a scientifically grounded and commercially sustainable pathway to improve diagnostic quality across Africa.

This is how diagnostics can be transformed from a bottleneck into a backbone—and how health systems can ensure that answers which already exist reach patients in time to matter.